AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
The FDA cannot conclude that the study data presented by Gould et al., (2009) in the American Journal of Psychiatry "affect the overall risk and benefit profile of stimulant medications used to treat attention-deficit/hyperactivity disorder in children." Gould and colleagues concluded that there may be an association between stimulant medications and sudden death in healthy children. However, due to the study's methodological …